The research team discovered that treatment with an Alzheimer s drug GM-CSF, which has pro-inflammatory, anti-inflammatory and immune regulatory properties, reverses learning and memory deficits, the loss of certain nerve cells, and other abnormalities in the brain in a mouse model of Down syndrome.
The results of the new study led by the University of Colorado Anschutz Campus have found that GM-CSF, which is an Alzheimer s drug, may improve cognitive function in people with Down syndrome.
Promising Alzheimer's Drug May Also Improve Memory in Down Syndrome and Normal Aging miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Partner Therapeutics, Inc. (PTx), a commercial biotech company, announces publication of results from investigator-sponsored pre-clinical.